tirzepatide and perimenopause for Peri Weight: Microdosing Help? Tirzepatide vs Semaglutide for Microdosing

Mechanistic studies suggest that combined receptor activation may influence multiple components of glucose homeostasis, including insulin secretion pathways, peripheral insulin signaling, and hepatic glucose metabolism

This assessment focused on various factors including randomized sequence generation, treatment allocation concealment, blinding, completeness of outcome data, as well as selective outcome reporting and other potential sources of bias

Among the most promising advances are GLP-1 receptor agonists like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound)

Your SheMed clinician can advise on which medication is most appropriate for your circumstances